Get started
GSK PLC CEDEAR EACH REPR 1/4 ADRGSK PLC CEDEAR EACH REPR 1/4 ADRGSK PLC CEDEAR EACH REPR 1/4 ADR

GSK PLC CEDEAR EACH REPR 1/4 ADR

No trades
See on Supercharts
Overview Financials News Ideas Discussions Technicals Seasonals
Bonds

GSK bonds

Below is the list of GSK PLC CEDEAR EACH REPR 1/4 ADR corporate bonds. Investors often opt for a company's bonds for their increased stability in times of market volatility. Study prices, yields, and other stats and find a reliable investment.
Symbol
YTM %
Volume
Price %
Coupon %
Maturity date
Outstanding amt
Face value
Min denom amt
Issuer
XXS217060907GLAXOSM.CAP. MTN 20/35MTN
6.07%072.60%1.63%2035-05-12750 M GBP1,000.00 GBP100,000.00 GBPGlaxoSmithKline Capital Plc
117RIGLAXOSMITHKLINE CAPITAL PLC 4.25% GTD SNR EMTN 18/12/456.06%8.46 K82.51%4.25%2045-12-18370.79 M GBP1,000.00 GBP100,000.00 GBPGlaxoSmithKline Capital Plc
883GIGLAXOSMITHKLINE CAPITAL PLC 5.25% GTD SNR EMTN 10/04/20425.87%094.80%5.25%2042-04-10477.82 M GBP1,000.00 GBP50,000.00 GBPGlaxoSmithKline Capital Plc
GGSK3981911GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043
5.78%190 K86.16%4.20%2043-03-18500 M USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital, Inc.
771ZCGLAXOSMITHKLINE CAPITAL PLC 6.375% GTD SNR EMTN 09/03/395.33%0108.25%6.38%2039-03-09631.3 M GBP1,000.00 GBP50,000.00 GBPGlaxoSmithKline Capital Plc
GGSK6023693GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035
5.10%6.6 M98.56%4.88%2035-04-15750 M USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital, Inc.
GGSK.GJGlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038
5.09%160 K109.98%6.38%2038-05-152.75 B USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital, Inc.
GGSK6023692GlaxoSmithKline Capital Plc FRN 12-MAR-2027
4.79%683 K100.06%4.83%2027-03-12600 M USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital Plc
AAG99GLAXOSMITHKLINE CAPITAL PLC 5.25% GTD SNR EMTN 19/12/20334.64%0103.68%5.25%2033-12-19574.17 M GBP1,000.00 GBP1,000.00 GBPGlaxoSmithKline Capital Plc
772WIGLAXOSMITHKLINE CAPITAL INC 5.375% GTD SNR NTS 15/04/20344.57%0105.28%5.38%2034-04-15500 M USD1,000.00 USD1,000.00 USDGlaxoSmithKline Capital, Inc.
UUS377373AH8GLAXOSM.CAP. 19/29
4.44%096.45%3.38%2029-06-011 B USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital Plc
GGSK6023695GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030
4.40%14.42 M100.38%4.50%2030-04-15850 M USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital, Inc.
UUS377372AN7GLAXOSMITHKLINE CAP.18/28
4.32%098.86%3.88%2028-05-151.75 B USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital, Inc.
XXS217060184GLAXOSM.CAP. MTN 20/28MTN
4.24%091.43%1.25%2028-10-12750 M GBP1,000.00 GBP100,000.00 GBPGlaxoSmithKline Capital Plc
GGSK6023691GlaxoSmithKline Capital Plc 4.315% 12-MAR-2027
4.13%150 K100.30%4.32%2027-03-12400 M USD1,000.00 USD2,000.00 USDGlaxoSmithKline Capital Plc
XXS293369275GSK CAP B.V. 24/36 MTN
3.56%097.47%3.25%2036-11-19600 M EUR1,000.00 EUR100,000.00 EURGSK Capital BV
XXS255381776GSK CAP B.V. 22/32 MTN
3.12%0100.06%3.13%2032-11-28700 M EUR1,000.00 EUR100,000.00 EURGSK Capital BV
XXS293369143GSK CAP B.V. 24/31 MTN
3.03%099.19%2.88%2031-11-19700 M EUR1,000.00 EUR100,000.00 EURGSK Capital BV
XXS182282979GLAXOSM.CAP. MTN 18/30MTN
2.84%095.34%1.75%2030-05-21750 M EUR1,000.00 EUR100,000.00 EURGlaxoSmithKline Capital Plc
XXS168152035GLAXOSM.CAP. MTN 17/29
2.59%095.43%1.38%2029-09-12500 M EUR1,000.00 EUR100,000.00 EURGlaxoSmithKline Capital Plc
XXS255381768GSK CAP B.V. 22/27 MTN
2.37%0101.43%3.00%2027-11-28500 M EUR1,000.00 EUR100,000.00 EURGSK Capital BV
GGX5BGLAXOSM.CAP. MTN 17/26
2.23%098.58%1.00%2026-09-12700 M EUR1,000.00 EUR100,000.00 EURGlaxoSmithKline Capital Plc
XXS182282812GLAXOSM.CAP. MTN 18/26MTN
2.09%099.29%1.25%2026-05-211 B EUR1,000.00 EUR100,000.00 EURGlaxoSmithKline Capital Plc
117RNGLAXOSMITHKLINE CAPITAL PLC 3.375% GTD SNR EMTN 20/12/20270.84%0112.19%3.38%2027-12-20307.77 M GBP1,000.00 GBP100,000.00 GBPGlaxoSmithKline Capital Plc
AAQ72GLAXOSMITHKLINE CAPITAL PLC 0.883% GTD SNR EMTN 21/09/20———0.88%2028-09-2142.5 B JPY100,000,000.00 JPY100,000,000.00 JPYGlaxoSmithKline Capital Plc